Skip to main content
FinSpry Logo
FinSpry
WST logo
WST
(NYSE)
West Pharmaceutical Services, Inc.
$254.80-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

West Pharmaceutical Services (WST) Stock Price & Financial Analysis

West Pharmaceutical Services Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$248.87 - $258.24
52-Week High$322.34
52-Week Low$187.43
Open$250.89
Volume794.99K
Average Volume (3M)794.99K
Market Cap18.52B
Shares Outstanding72.70M
P/E Ratio (TTM)37.22
Forward P/E37.14
Price to Sales (P/S)5.98
Price to Book (P/B)5.79
EV/EBITDA23.26
Revenue (TTM)3.07B
Net Income (TTM)493.70M
Free Cash Flow (TTM)468.90M
EPS (TTM)$6.79
Profit Margin16.06%
Operating Margin20.09%
Return on Equity (ROE)15.54%
Debt to Equity0.13
50-Day MA$243.11
200-Day MA$253.42
52-Week Change14.80%
Annual Dividend$0.86
Dividend Yield0.34%
Payout Ratio12.66%
Last Dividend Ex-DateApr 29, 2026

Frequently Asked Questions About West Pharmaceutical Services

What is the current stock price for WST?

As of the latest trading session, WST stock trades at $254.80. The 52-week range is $187.43–$322.34, with a day range of $248.87–$258.24.

What is the P/E ratio for WST?

West Pharmaceutical Services's trailing P/E ratio is 37.2, meaning investors pay $37.2 for every $1 of annual earnings. The forward P/E is 37.1, reflecting analyst expectations for future earnings. West Pharmaceutical Services operates in the Healthcare sector.

Does WST pay dividends?

Yes, West Pharmaceutical Services pays a 0.34% annual dividend yield ($0.86 per share). The payout ratio is 12.7%. The last ex-dividend date was 2026-04-29.

What do analysts recommend for WST?

Based on 2 analysts, the consensus for WST is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of WST?

West Pharmaceutical Services's market capitalization is $18.52B, classifying it as a large-cap company. West Pharmaceutical Services operates in the Healthcare sector within the Medical Instruments & Supplies industry.